PROSION
Signal active
Organization
Contact Information
Overview
PROSION Therapeutics is a drug development company with a proprietary platform to adress unmet medical needs (e.g. cancer, diabetes) by unlocking undruggables
About
Industries
Pharmaceutical, Medical
Founded
2020
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
PROSION headquartered in Europe, operates in the Pharmaceutical, Medical sector. The company focuses on Pharmaceutical and has secured $47.2M in funding across 16 round(s). With a team of 11-50 employees, PROSION is actively contributing to advancements in Pharmaceutical. Their latest funding round, Grant - PROSION, raised $3.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
1
Lead Investors
0
Total Funding Amount
$3.0M
Details
1
PROSION has raised a total of $3.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Seed |
Investors
PROSION is funded by 4 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| PROSION | - | FUNDING ROUND - PROSION | undefined |
| Freigeist Capital | - | FUNDING ROUND - Freigeist Capital | undefined |
| PROSION | - | FUNDING ROUND - PROSION | 3.0M |
| European Innovation Council | - | FUNDING ROUND - European Innovation Council | 3.0M |
Recent Activity
There is no recent news or activity for this profile.